1. Home
  2. ADUR vs TLSI Comparison

ADUR vs TLSI Comparison

Compare ADUR & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADUR
  • TLSI
  • Stock Information
  • Founded
  • ADUR 2011
  • TLSI 2010
  • Country
  • ADUR Canada
  • TLSI United States
  • Employees
  • ADUR N/A
  • TLSI N/A
  • Industry
  • ADUR
  • TLSI Medical Specialities
  • Sector
  • ADUR
  • TLSI Health Care
  • Exchange
  • ADUR NYSE
  • TLSI Nasdaq
  • Market Cap
  • ADUR 154.9M
  • TLSI 124.9M
  • IPO Year
  • ADUR N/A
  • TLSI N/A
  • Fundamental
  • Price
  • ADUR $5.50
  • TLSI $4.53
  • Analyst Decision
  • ADUR
  • TLSI Strong Buy
  • Analyst Count
  • ADUR 0
  • TLSI 5
  • Target Price
  • ADUR N/A
  • TLSI $12.10
  • AVG Volume (30 Days)
  • ADUR 126.5K
  • TLSI 32.8K
  • Earning Date
  • ADUR 01-01-0001
  • TLSI 11-14-2024
  • Dividend Yield
  • ADUR N/A
  • TLSI N/A
  • EPS Growth
  • ADUR N/A
  • TLSI N/A
  • EPS
  • ADUR N/A
  • TLSI N/A
  • Revenue
  • ADUR $247,485.00
  • TLSI $26,891,000.00
  • Revenue This Year
  • ADUR N/A
  • TLSI $61.76
  • Revenue Next Year
  • ADUR N/A
  • TLSI $47.30
  • P/E Ratio
  • ADUR N/A
  • TLSI N/A
  • Revenue Growth
  • ADUR 98.59
  • TLSI 67.92
  • 52 Week Low
  • ADUR $1.34
  • TLSI $3.33
  • 52 Week High
  • ADUR $7.00
  • TLSI $10.42
  • Technical
  • Relative Strength Index (RSI)
  • ADUR N/A
  • TLSI 58.12
  • Support Level
  • ADUR N/A
  • TLSI $3.74
  • Resistance Level
  • ADUR N/A
  • TLSI $4.66
  • Average True Range (ATR)
  • ADUR 0.00
  • TLSI 0.37
  • MACD
  • ADUR 0.00
  • TLSI 0.05
  • Stochastic Oscillator
  • ADUR 0.00
  • TLSI 88.04

About ADUR ADURO CLEAN TECHNOLOGIES INC

Aduro Clean Technologies Inc is a developer of patented water-based technologies to chemically recycle plastics and transform heavy crude and renewable oils into feedstocks and higher-value fuels. The company's technology activates unique properties of water in a chemistry platform that operates at relatively low temperatures and costs.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Share on Social Networks: